Home › Funds › BlackBarn Capital Partners LP › VKTX

BlackBarn Capital Partners LP position in VKTX

VIKING THERAPEUTICS INC · Health Care

BlackBarn Capital Partners LP reported holding 250,000 shares of VKTX (VIKING THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$9.8M, representing 0.90% of its reported portfolio and ranking #18 among its reported holdings. BlackBarn Capital Partners LP has disclosed VKTX holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

Latest position (Q2 2026)250.00K sh
Reported value held$9.75M
Portfolio Weight0.90%
First reportedQ2 2025
Last changeReduce
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How BlackBarn Capital Partners LP's VKTX position evolved

BlackBarn Capital Partners LP first disclosed a stake in VKTX in Q2 2025 at 350,000 shares (US$9.3M). The position peaked in Q1 2026 at 621,450 shares, worth US$20.2M. Across 5 filings, BlackBarn Capital Partners LP increased the stake 3 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 250,000 shares valued at US$9.8M — a reduction of -371,450 shares quarter over quarter.. Notable position changes include a 43% increase in Q3 2025 (shares rose 34% over the following quarter), a 60% trim in Q2 2026 (shares fell 16% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2025 350.00K $9.28M New
Q3 2025 500.00K $13.14M Add
Q4 2025 550.00K $19.35M Add
Q1 2026 621.45K $20.22M Add
Q2 2026 250.00K $9.75M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About VKTX and 13F data

VKTX (VIKING THERAPEUTICS INC) is a Health Care company. 35 other funds we track also report a position in VKTX — the largest reported positions include Vestal Point Capital, LP (US$26.5M), Eversept Partners, LP (US$23.5M), ADAR1 Capital Management, LLC (US$22.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding VKTX

All VKTX fund holders →

FAQ

How long has BlackBarn Capital Partners LP held VKTX?

BlackBarn Capital Partners LP has disclosed VKTX holdings in 5 of the last 5 reported quarters, going back to Q2 2025.

What is BlackBarn Capital Partners LP's current position in VKTX?

As of Q2 2026, BlackBarn Capital Partners LP holds 250.00K shares of VKTX (VIKING THERAPEUTICS INC), valued at $9.75M, representing 0.90% of its reported portfolio and ranking #18.

Has BlackBarn Capital Partners LP been buying or selling VKTX?

In the latest 13F filing (Q2 2026), BlackBarn Capital Partners LP reduced its position in VKTX. The position peaked in Q1 2026 at 621.45K shares.

Which other funds hold VKTX?

Other major institutional holders of VKTX include Vestal Point Capital, LP, Eversept Partners, LP, ADAR1 Capital Management, LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.